Myricx Pharma Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Myricx Pharma Ltd's estimated annual revenue is currently $1.2M per year.
- Myricx Pharma Ltd's estimated revenue per employee is $55,357
Employee Data
- Myricx Pharma Ltd has 21 Employees.
- Myricx Pharma Ltd grew their employee count by 62% last year.
Myricx Pharma Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Clinical Development | Reveal Email/Phone |
Myricx Pharma Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is Myricx Pharma Ltd?
We are a drug discovery company selectively targeting protein myristoylation for the treatment of cancer and viral diseases
keywords:N/A
N/A
Total Funding
21
Number of Employees
$1.2M
Revenue (est)
62%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Myricx Pharma Ltd News
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer, today unveiled an initial £4.5 million in seed financing from experienced venture investors, Sofinnova Partners and Brando ...
Myricx Pharma, a Stevenage, United Kingdom-based drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer, raised £4.5m in seed financing. Backers included Sofinnova Partners and Brandon Capital Partners. T ...
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer, today unveiled an initial £4.5 million in seed financing from experienced venture investors, Sofinnova Partners and Brando ...
Other Companies in Stevenage
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.3M | 23 | N/A | N/A |
#2 | $5.3M | 24 | 9% | N/A |
#3 | $4.3M | 26 | 37% | N/A |
#4 | $3.6M | 33 | 10% | N/A |
#5 | $7.8M | 36 | 13% | N/A |